Agenus (AGEN) Appoints Jennifer Buell to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Agenus (AGEN) Appoints Jennifer Buell to its Board

Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors

June 17, 2024 7:00 AM EDT

Strategic leadership to drive next phase of growth for the company

LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc. (Agenus) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, is pleased to announce the appointment of Dr. Jennifer Buell to its Board of Directors, on June 11, 2024, effective immediately. Dr. Buell will maintain her active and ongoing role as the President and CEO of MiNK Therapeutics, in addition to her responsibilities as Chairman of the Executive Council at Agenus. Her continued leadership at MiNK ensures a seamless integration of... More